Your browser doesn't support javascript.
loading
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
Sereti, Irini; Shaw-Saliba, Kathryn; Dodd, Lori E; Dewar, Robin L; Laverdure, Sylvain; Brown, Shawn; Mbaya, Olivier Tshiani; Muyembe Tamfum, Jean Jacques; Mblala-Kingebeni, Placide; Sow, Ydrissa; Akpa, Esther; Haidara, Mory Cherif; Fouth Tchos, Karine; Beavogui, Abdoul Habib; Neal, Aaron; Arlinda, Dona; Lokida, Dewi; Grue, Louis; Smolskis, Mary; McNay, Laura A; Gayedyu-Dennis, Dehkontee; Ruiz-Palacios, Guillermo M; Montenegro-Liendo, Abelardo; Tounkara, Moctar; Samake, Seydou; Jargalsaikhan, Ganbolor; Zulkhuu, Delgersaikhan; Weyers, Shera; Bonnett, Tyler; Potter, Gail E; Stevens, Randy; Rupert, Adam; Aboulhab, Jamila; Biampata, Jean-Luc; Delamo, Alexandre; Camara, Bienvenu Salim; Kosasih Indonesia, Herman; Karyana, Muhammad; Duworko, James T; Regalado-Pineda, Justino; Guerra-de-Blas, Paola Del Carmen; Doumbia, Seydou; Dabitao, Djeneba; Dashdorj, Naranjargal; Dashdorj, Naranbaatar; Newell, Kevin; Francis, Alyson; Rubenstein, Kevin; Bera, Victoria; Gulati, Iman.
Afiliación
  • Sereti I; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Shaw-Saliba K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Dodd LE; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Dewar RL; Virus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Brown S; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Mbaya OT; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Muyembe Tamfum JJ; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Mblala-Kingebeni P; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Sow Y; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Akpa E; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Haidara MC; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Fouth Tchos K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Neal A; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Arlinda D; Ministry of Health, Jakarta, Indonesia.
  • Lokida D; Indonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
  • Grue L; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Smolskis M; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • McNay LA; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Gayedyu-Dennis D; Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
  • Ruiz-Palacios GM; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
  • Montenegro-Liendo A; The Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
  • Tounkara M; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Samake S; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Jargalsaikhan G; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Zulkhuu D; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Weyers S; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Bonnett T; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Potter GE; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Stevens R; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Rupert A; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Aboulhab J; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Biampata JL; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Delamo A; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Camara BS; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Kosasih Indonesia H; Indonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
  • Karyana M; Ministry of Health, Jakarta, Indonesia.
  • Duworko JT; Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
  • Regalado-Pineda J; Subdirección de Medicina, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico.
  • Guerra-de-Blas PDC; The Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
  • Doumbia S; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Dabitao D; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Dashdorj N; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Dashdorj N; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Newell K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Francis A; Systex, Inc, Rockville, Maryland, United States of America.
  • Rubenstein K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Bera V; Systex, Inc, Rockville, Maryland, United States of America.
  • Gulati I; Systex, Inc, Rockville, Maryland, United States of America.
PLoS One ; 17(9): e0273914, 2022.
Article en En | MEDLINE | ID: mdl-36107966

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...